CVS Health Corporation (CVS)
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Expands Its Nationwide Care Network With Rite Aid Acquisition
CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, CVS Health (CVS) closed at $77.9, marking a +1.51% move from the previous day.
CVS says over 81% of members are in high-rated Medicare Advantage plans for 2026
CVS Health said on Thursday that its Aetna insurance business has over 81% of members in Medicare Advantage plans that are rated 4 stars or higher for 2026.
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider
CVS Health (CVS) reached $76.87 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.
CVS Health: A Deeply Undervalued Giant Investors Keep Ignoring
CVS Health remains a solid, undervalued business, despite recent underperformance, versus the S&P 500 and ongoing margin pressures. Q2/25 results showed strong revenue growth but declining operating income and earnings, with updated guidance raising adjusted EPS expectations for 2025. Intrinsic value calculations suggest CVS Health is deeply undervalued, with a realistic fair value estimate of $135 per share, offering significant upside.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy
Healthcare investing has felt like walking through quicksand this year.
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
